Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Category Archives: Controlled drugs
Rapid Update 1 – November 2020: Prescribing of opioid drugs in the UK for patients with non-cancer pain
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Rapid Update 2 – October 2019: Public health assessment finds a quarter of adults in England prescribed medicines associated with dependence or withdrawal
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Rapid Update 1- June 2018: Opioids: interventions to reduce use in chronic non-cancer pain
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Rapid Update 2- December 2017: Gabapentin and opioids: Observational study finds increased risk of opioid-related death when used in combination
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
Rapid Update 1- August 2017: Alzheimer’s disease: increased risk of pneumonia observed in people treated with benzodiazepines
Healthcare professionals working in organisations that subscribe to ScriptSwitch may register to request access – please submit your details via the ‘register’ link at the top of this page.
NPC Archive Item: NPC Podcast – 25th September 2009
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Steve Morris talks to Chris Harris, Controlled Drugs Policy lead at the Department for Health, and Gillian Arr-Jones, Chief Pharmacist at the Care Quality Commission (CQC), about the recent […]